Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Corixa receives milestone payment for lung cancer vaccine

Aug. 3, 2001

Novel leukemia drug receives positive opinion from CPMP

Aug. 3, 2001

GC-C agonists inhibit colon cancer cell proliferation

Aug. 3, 2001

Derivatives useful as antiproliferative agents patented by Pfizer

Aug. 2, 2001

FDA and NCI announce new clinical proteomics program

Aug. 2, 2001

Desoxyepothilones B and F promising new cancer therapeutics

Aug. 2, 2001

Thalidomide improves survival in multiple myeloma patients

Aug. 1, 2001

Phase II trial of E21R for acute myeloid leukemia to start

July 31, 2001

Pegylated formulations of rHuTNF-alpha with improved properties prepared in China

July 30, 2001

FLT3 tyrosine kinase inhibitor exerts specific cytotoxicity against certain mutated AML blasts

July 30, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...